当前位置: X-MOL 学术Clin. Transl. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical chimeric antigen receptor T-cell therapy: a new and promising treatment modality for glioblastoma
Clinical & Translational Immunology ( IF 5.8 ) Pub Date : 2021-08-11 , DOI: 10.1002/cti2.1331
Michael P Brown , Lisa M Ebert , Tessa Gargett

Correction to: Clin Trans Immunol 2019; 8: e1050. doi: https://doi.org/10.1002/cti2.1050. Published online 20 May 2019.

The authors inadvertently excluded a funding body in the Acknowledgments section. The corrected version appears below:

ACKNOWLEDGMENTS

We acknowledge support from the Cancer Council SA Beat Cancer Project Hospital Research Support Package, a Cancer Council Early Career Research Fellowship, the Health Services Charitable Gifts Board (Adelaide) and The Hospital Research Foundation.

The authors apologise for this error.



中文翻译:

临床嵌合抗原受体 T 细胞疗法:一种新的、有前景的胶质母细胞瘤治疗方式

更正: Clin Trans Immunol 2019;8:e1050。doi:https://doi.org/10.1002/cti2.1050。2019 年 5 月 20 日在线发布。

作者无意中在致谢部分排除了资助机构。修正后的版本如下所示:

致谢

我们感谢 Cancer Council SA Beat Cancer Project Hospital Research Support Package、癌症委员会早期职业研究奖学金、卫生服务慈善礼品委员会(阿德莱德)和医院研究基金会的支持。

作者为这个错误道歉。

更新日期:2021-08-12
down
wechat
bug